Glucagon-like peptide-1 receptor agonists and mental health: A meta-analysis of randomized controlled trials

被引：6
|
作者：
Silverii, Giovanni Antonio [1 ,3 ]
Marinelli, Christian [1 ]
Mannucci, Edoardo [1 ]
Rotella, Francesco [2 ]
机构：
[1] Florence Univ, Expt & Clin Biomed Sci Dept, Diabetol Unit, Florence, Italy
[2] Florence Univ, Hlth Sci Dept, Psychiat Unit, Florence, Italy
[3] Univ Florence, Expt & Clin Biomed Sci Mario Serio Dept, Largo Brambilla 3, I-50134 Florence, Italy
来源：
DIABETES OBESITY & METABOLISM | 2024年 / 26卷 / 06期
关键词：
QUALITY;
D O I：
10.1111/dom.15538
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2505 / 2508
页数：4
相关论文
共 50 条
  • [31] The cardiovascular effects of glucagon-like peptide-1 receptor agonists: a trial sequential analysis of randomized controlled trials
    Wu, S.
    Sun, F.
    Zhang, Y.
    Yang, Z.
    Hong, T.
    Chen, Y.
    Zhan, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (01) : 7 - 13
  • [32] Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Cheng, Liang
    Hu, Yun
    Li, Yun-Yun
    Cao, Xin
    Bai, Ning
    Lu, Ting-Ting
    Li, Guo-Qing
    Li, Na
    Wang, An-Ning
    Mao, Xiao-Ming
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (07)
  • [33] Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: A meta-analysis of randomized controlled trials
    Zhang, Yuan
    Chen, Guanhua
    Wang, Weimin
    Yang, Donghui
    Zhu, Dalong
    Jing, Yali
    BONE, 2025, 192
  • [34] Effects of Glucagon-Like Peptide-1 Receptor Agonists on Patients With or Without Heart Failure: A Meta-Analysis of Randomized Control Trials
    Obata, Shota
    Miyamoto, Yoshihisa
    Slipczuk, Leandro
    Takagi, Hisato
    Kuno, Toshiki
    CIRCULATION, 2022, 146
  • [35] Glucagon-Like Peptide-1 Receptor Agonists in the Management of Obesity: An Economics Meta-Analysis
    Bloomfield, Grace C.
    Chen, Yuan
    Cunningham, Marcus H.
    Bartoletti, Sebastiano
    Azagury, Dan E.
    Alimi, Yewande R.
    Prindeze, Nicholas
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S25 - S25
  • [36] Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis
    Monami, Matteo
    Dicembrini, Ilaria
    Omarchionni, Niccolo
    Rotella, Carlo M.
    Mannucci, Edoardo
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [37] Glucose Lowering Efficacy of Glucagon-Like Peptide-1 Receptor Agonists: A Meta-Analysis
    Vilsboll, Tina
    Christensen, Mikkel
    Knop, Filip K.
    Gluud, Lise L.
    DIABETES, 2011, 60 : A295 - A295
  • [38] Glucagon-like peptide-1 receptor agonists and stroke: A systematic review and meta-analysis of cardiovascular outcome trials
    Adamou, Anastasia
    Barkas, Fotios
    Milionis, Haralampos
    Ntaios, George
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (08) : 876 - 887
  • [39] An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
    De Giorgi, Riccardo
    Ghenciulescu, Ana
    Dziwisz, Oliwia
    Taquet, Maxime
    Adler, Amanda I.
    Koychev, Ivan
    Upthegrove, Rachel
    Solmi, Marco
    Mccutcheon, Robert
    Pillinger, Toby
    Cowen, Philip J.
    Harmer, Catherine J.
    NATURE MENTAL HEALTH, 2025, 3 (03):
  • [40] An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
    De Giorgi, Riccardo
    Ghenciulescu, Ana
    Dziwisz, Oliwia
    Taquet, Maxime
    Adler, Amanda I.
    Koychev, Ivan
    Upthegrove, Rachel
    Solmi, Marco
    Mccutcheon, Robert
    Pillinger, Toby
    Cowen, Philip J.
    Harmer, Catherine J.
    NATURE MENTAL HEALTH, 2025,
12345